Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 8/20 | 0.47 |
| ▸ | ADH1C | P00326 | 5/20 | 0.47 |
| ▸ | ADH1B | P00325 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | PHGDH | O43175 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.31 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | XBP1 | P17861 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9660578 | 1.00 | ADH1A (0.47) | ADH1AADH1CADH1BL3MBTL1MEN1 | |
| SCHEMBL302802 | 1.00 | ADH1A (0.47) | ADH1AADH1CADH1BL3MBTL1MEN1 | |
| SCHEMBL967214 | 0.98 | ADH1A (0.43) | ADH1AADH1CADH1BL3MBTL1MEN1 | |
| SCHEMBL969251 | 0.95 | — | — | |
| SCHEMBL967293 | 0.88 | — | — | |
| SCHEMBL304405 | 0.83 | ADH1A (0.50) | ADH1AADH1CADH1B | |
| SCHEMBL9660549 | 0.83 | ADH1A (0.50) | ADH1AADH1CADH1B | |
| SCHEMBL9660999 | 0.83 | ADH1A (0.50) | ADH1AADH1CADH1B | |
| SCHEMBL3024929 | 0.80 | ADH1A (0.48) | ADH1AADH1C | |
| SCHEMBL9658873 | 0.79 | ADH1A (0.43) | ADH1AADH1CL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0517262-A1 | Trifluorothymidine derivatives, process for producing the same and anti-cancer agent containing the same | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1992-12-09 | — | — | EP | disclosed |